Hongjuan Xu
Changsha, 410008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A triple combination strategy for nasopharyngeal carcinoma: Aptamer-guided liposomal chemotherapy, engineered NK cells, and Fc-enhanced PD-L1 antibody therapy.
Journal: Acta pharmaceutica Sinica. B
Published: August 13, 2025
Parkinson Disease -Targeted Nanocapsules for Synergistic Treatment: Combining Dopamine Replacement and Neuroinflammation Mitigation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 01, 2024
Embryonic stem cell related gene regulates alternative splicing of transcription factor 3 to maintain human embryonic stem cells' self-renewal and pluripotency.
Journal: Stem cells (Dayton, Ohio)
Published: September 19, 2023
Aptamers combined with immune checkpoints for cancer detection and targeted therapy: A review.
Journal: International journal of biological macromolecules
Published: August 03, 2023
Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: July 15, 2022
Mechanism of Liver Regeneration During ALPPS.
Journal: Frontiers in cell and developmental biology
Published: April 09, 2022
TBL1X and Flot2 form a positive feedback loop to promote metastasis in nasopharyngeal carcinoma.
Journal: International journal of biological sciences
Published: October 15, 2021
Suppressing ERK Pathway Impairs Glycochenodeoxycholate-Mediated Survival and Drug-Resistance in Hepatocellular Carcinoma Cells.
Journal: Frontiers in oncology
Published: February 04, 2021
Correction: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.
Journal: Signal transduction and targeted therapy
Published: November 14, 2020
Last Updated: 09/26/2026